Kevin M. Cooper

Kevin M. Cooper

Auto-generated profile, based on publicly available information

Kevin M. Cooper

School of Biological Sciences, Queen's University Belfast, Belfast, UK

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Food Additives & Contaminants
Verified
Journal Article
Closed access
KCK. M Cooper
K. M Cooper
PMP. P. J Mulder
P. P. J Mulder
JRJ. A van Rhijn
J. A van Rhijn
LKL Kovacsics
L Kovacsics
RMR. J McCracken
R. J McCracken
DKD. G Kennedy
D. G Kennedy
Depletion of the nitrofuran antibiotics furazolidone, furaltadone, nitrofurantoin and nitrofurazone and their tissue-bound metabolites AOZ, AMOZ, AHD and SEM from pig muscle, liver and kidney tissues is described. Groups of pigs were given feed medicated with one of the nitrofuran drugs at a therapeutic concentration (400 mg kg−1) for ten days. Animals were slaughtered at intervals and tissue samples collected for analysis for six weeks following withdrawal of medicated feed. These samples were analysed both for parent nitrofurans (using LC-MS/MS and HPLC-UV), and for tissue-bound metabolites (using LC-MS/MS). The parent drugs were detectable only sporadically and only in pigs subjected to no withdrawal period whatsoever. This confirms the instability of the four major nitrofuran antibiotics in edible tissues. In contrast, the metabolites accumulated to high concentrations in tissues (ppm levels) and had depletion half lives of between 5.5 and 15.5 days. The metabolites of all four drugs were still readily detectable in tissues six weeks after cessation of treatment. This emphasizes the benefits of monitoring for the stable metabolites of the nitrofurans.

14 May 2014 in Cancer Research
Verified
Journal Article
Closed access
PDF file
KSKienan Savage
Kienan Savage
KMKyle Matchett
Kyle Matchett
EBEliana M. Barros
Eliana M. Barros
KCKevin M. Cooper
Kevin M. Cooper
GIGareth W. Irwin
Gareth W. Irwin
DHD. Paul Harkin
D. Paul Harkin
Germline mutations in BRCA1 predispose carriers to a high incidence of breast and ovarian cancers. BRCA1 functions to maintain genomic stability through critical roles in DNA repair, cell-cycle arrest, and transcriptional control. A major question has been why BRCA1 loss or mutation leads to tumors mainly in estrogen-regulated tissues, given that BRCA1 has essential functions in all cell types. Here, we report that estrogen and estrogen metabolites can cause DNA double-strand breaks (DSB) in estrogen receptor-α–negative breast cells and that BRCA1 is required to repair these DSBs to prevent metabolite-induced genomic instability. We found that BRCA1 also regulates estrogen metabolism and metabolite-mediated DNA damage by repressing the transcription of estrogen-metabolizing enzymes, such as CYP1A1, in breast cells. Finally, we used a knock-in human cell model with a heterozygous BRCA1 pathogenic mutation to show how BRCA1 haploinsufficiency affects these processes. Our findings provide pivotal new insights into why BRCA1 mutation drives the formation of tumors in estrogen-regulated tissues, despite the general role of BRCA1 in DNA repair in all cell types. Cancer Res; 74(10); 2773–84. ©2014 AACR.

1 May 2007 in Analytica Chimica Acta
Verified
Journal Article
Closed access
KCKevin M. Cooper
Kevin M. Cooper
JSJeanne V. Samsonova
Jeanne V. Samsonova
LPLaura Plumpton
Laura Plumpton
CEChristopher T. Elliott
Christopher T. Elliott
DKD. Glenn Kennedy
D. Glenn Kennedy

1 June 2005 in Analytica Chimica Acta
Verified
Journal Article
Closed access
IDIva Diblikova
Iva Diblikova
KCKevin M. Cooper
Kevin M. Cooper
DKD. Glenn Kennedy
D. Glenn Kennedy
MFMilan Franek
Milan Franek

1 August 2004 in Analytica Chimica Acta
Verified
Journal Article
Closed access
KCKevin M. Cooper
Kevin M. Cooper
ACAnthony Caddell
Anthony Caddell
CEChristopher T. Elliott
Christopher T. Elliott
DKD.GLenn Kennedy
D.GLenn Kennedy

1 October 2018 in Chimia
Verified
Journal Article
Open access
CCChristophe Cavin
Christophe Cavin
GCGeoffrey Cottenet
Geoffrey Cottenet
KCKevin M. Cooper
Kevin M. Cooper
PZPascal Zbinden
Pascal Zbinden
Meat has been identified as one of the food categories at most risk of food fraud. Meat species substitution has been in the spotlight with the European horse meat scandal in 2013. Analysis of cases reported on the web shows that incidents of meat substitution are still recurring worldwide. Altogether these cases highlight significant weaknesses in the supply chain transparency and traceability of raw meat materials. This has triggered recent progress from the food industry to apply new software tools enabling the mapping of meat supply chains. Nevertheless, a meat vulnerability assessment showed that meat and derivatives are highly susceptible to many fraudulent malpractices. Therefore, more effective measures are needed to manage the risk and new analytical solutions are required to increase the deterrence of meat adulteration and rapid detection of fraud. DNA-based methods have evolved rapidly as shown with the application of the new LCD array and Next Generation Sequencing (NGS) in order to detect broad meat species adulteration. Moreover, new technologies such as NGS together with the Rapid Evaporative Ionization Mass Spectrometry (REIMS) are emerging as a really promising association of analytical approaches for rapid detection of several malpractices.